Average Co-Inventor Count = 4.19
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aegera Therapeutics, Inc. (8 from 24 patents)
2. Apoptogen, Inc. (5 from 5 patents)
3. University of Ottawa (2 from 163 patents)
15 patents:
1. 7776552 - Mammalian IAP gene family, primers, probes and detection methods
2. 7087584 - Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
3. 7067281 - Mammalian IAP gene family, primers, probes and detection methods
4. 6946544 - XAF genes and polypeptides: methods and reagents for modulating apoptosis
5. 6689562 - Mammalian IAP gene family, primers, probes and detection methods
6. 6656704 - Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
7. 6541457 - Mammalian IAP gene family, primers, probes and detection methods
8. 6495339 - Method of identifying a compound that modulates XAF-mediated apoptosis
9. 6300492 - Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
10. 6171821 - XIAP IRES and uses thereof
11. 6159709 - XIAP IRES and uses thereof
12. 6156535 - Mammalian IAP gene family, primers, probes, and detection methods
13. 6133437 - Modulation of IAPs for the treatment of proliferative diseases
14. 6107041 - Detection and modulation of IAPS for the diagnosis and treatment of
15. 6107088 - XAF genes and polypeptides: methods and reagents for modulating apoptosis